Cargando…

Pediatric Behçet's Disease

Behçet's Disease (BD) is a systemic vasculitis firstly described as a disorder causing aphthous lesion in oral and genital mucosae and uveitis. The disease has an extremely unique distribution characterized by the highest incidence in communities living along the historical Silk road. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildiz, Mehmet, Haslak, Fatih, Adrovic, Amra, Sahin, Sezgin, Koker, Oya, Barut, Kenan, Kasapcopur, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886701/
https://www.ncbi.nlm.nih.gov/pubmed/33614684
http://dx.doi.org/10.3389/fmed.2021.627192
_version_ 1783651851917328384
author Yildiz, Mehmet
Haslak, Fatih
Adrovic, Amra
Sahin, Sezgin
Koker, Oya
Barut, Kenan
Kasapcopur, Ozgur
author_facet Yildiz, Mehmet
Haslak, Fatih
Adrovic, Amra
Sahin, Sezgin
Koker, Oya
Barut, Kenan
Kasapcopur, Ozgur
author_sort Yildiz, Mehmet
collection PubMed
description Behçet's Disease (BD) is a systemic vasculitis firstly described as a disorder causing aphthous lesion in oral and genital mucosae and uveitis. The disease has an extremely unique distribution characterized by the highest incidence in communities living along the historical Silk road. Although our understanding of the etiopathogenesis of BD has expanded over time, there are still lots of unidentified points in the underlying mechanisms of the disease. The accepted opinion in the light of the current knowledge is that various identified and/or unidentified infectious and/or environmental triggers can take a role as a trigger in individuals with genetic susceptibility. Although the disease usually develops in young adulthood, it is reported that about 15–20% of all Behçet's patients develop in childhood. Pediatric BD differs from adult BD not only with the age of onset but also in the frequency and distribution of clinical findings, disease severity and outcome. While gastrointestinal system involvement, neurological findings, arthralgia and positive family history are more common in children, genital lesions and vascular lesions are more common in adult patients. In addition, a better disease outcome with lower severity score and activity index has been reported in children. The diagnosis of the disease is made according to clinical findings. It can be challenging to diagnose the disease due to the absence of a specific diagnostic test, and the long time interval from the first finding of the disease to the full-blown disease phenotype in pediatric cases. Therefore, many classification criteria have been proposed so far. The widely accepted ones are proposed by the International Study Group. The new sets of classification criteria which is the only one for pediatric BD were also developed for pediatric cases by the PEDBD group. The primary goal for the treatment is preventing the organ damages by suppressing the ongoing inflammation and forestalling the disease flares. The treatment of the BD can be onerous due to its multisystemic nature and a multidisciplinary approach is essential for the management of the patients. In this review article, the definition, clinical findings, epidemiology, etiopathogenesis, and treatment will be discussed.
format Online
Article
Text
id pubmed-7886701
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78867012021-02-18 Pediatric Behçet's Disease Yildiz, Mehmet Haslak, Fatih Adrovic, Amra Sahin, Sezgin Koker, Oya Barut, Kenan Kasapcopur, Ozgur Front Med (Lausanne) Medicine Behçet's Disease (BD) is a systemic vasculitis firstly described as a disorder causing aphthous lesion in oral and genital mucosae and uveitis. The disease has an extremely unique distribution characterized by the highest incidence in communities living along the historical Silk road. Although our understanding of the etiopathogenesis of BD has expanded over time, there are still lots of unidentified points in the underlying mechanisms of the disease. The accepted opinion in the light of the current knowledge is that various identified and/or unidentified infectious and/or environmental triggers can take a role as a trigger in individuals with genetic susceptibility. Although the disease usually develops in young adulthood, it is reported that about 15–20% of all Behçet's patients develop in childhood. Pediatric BD differs from adult BD not only with the age of onset but also in the frequency and distribution of clinical findings, disease severity and outcome. While gastrointestinal system involvement, neurological findings, arthralgia and positive family history are more common in children, genital lesions and vascular lesions are more common in adult patients. In addition, a better disease outcome with lower severity score and activity index has been reported in children. The diagnosis of the disease is made according to clinical findings. It can be challenging to diagnose the disease due to the absence of a specific diagnostic test, and the long time interval from the first finding of the disease to the full-blown disease phenotype in pediatric cases. Therefore, many classification criteria have been proposed so far. The widely accepted ones are proposed by the International Study Group. The new sets of classification criteria which is the only one for pediatric BD were also developed for pediatric cases by the PEDBD group. The primary goal for the treatment is preventing the organ damages by suppressing the ongoing inflammation and forestalling the disease flares. The treatment of the BD can be onerous due to its multisystemic nature and a multidisciplinary approach is essential for the management of the patients. In this review article, the definition, clinical findings, epidemiology, etiopathogenesis, and treatment will be discussed. Frontiers Media S.A. 2021-02-03 /pmc/articles/PMC7886701/ /pubmed/33614684 http://dx.doi.org/10.3389/fmed.2021.627192 Text en Copyright © 2021 Yildiz, Haslak, Adrovic, Sahin, Koker, Barut and Kasapcopur. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yildiz, Mehmet
Haslak, Fatih
Adrovic, Amra
Sahin, Sezgin
Koker, Oya
Barut, Kenan
Kasapcopur, Ozgur
Pediatric Behçet's Disease
title Pediatric Behçet's Disease
title_full Pediatric Behçet's Disease
title_fullStr Pediatric Behçet's Disease
title_full_unstemmed Pediatric Behçet's Disease
title_short Pediatric Behçet's Disease
title_sort pediatric behçet's disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886701/
https://www.ncbi.nlm.nih.gov/pubmed/33614684
http://dx.doi.org/10.3389/fmed.2021.627192
work_keys_str_mv AT yildizmehmet pediatricbehcetsdisease
AT haslakfatih pediatricbehcetsdisease
AT adrovicamra pediatricbehcetsdisease
AT sahinsezgin pediatricbehcetsdisease
AT kokeroya pediatricbehcetsdisease
AT barutkenan pediatricbehcetsdisease
AT kasapcopurozgur pediatricbehcetsdisease